Silverback Therapeutics and ARS Pharmaceuticals, Inc.Conference Call July 21, 2022 at 5:00 PM EDT Conference Call
Silverback Therapeutics and ARS Pharmaceuticals Announce Merger
Transaction to support potential commercialization of neffy™, ARS’s needle-free epinephrine nasal spray Well-funded with at least three years of operating runway expectedCompanies to host conference call today, July 21, 2022, at 5:00 p.m. ET SEATTLE and SAN DIEGO – July 21, 2022 – Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) and ARS...